2000:

November 15, 2000
FibroGen's P4H Inhibitor Slows Myocardial Fibrosis and Improves Survival

October 31, 2000
FibroGen's Recombinant Gelatin To Be Highlighted at American Association of Pharmaceutical Scientists Annual Meeting

September 28, 2000
FibroGen Closes $56.5 Million Private Financing

July 26, 2000
FibroGen and ZymoGenetics Establish Research Collaboration for Development of Wound Management Products

May 17, 2000
FibroGen Presents the Advantages of Synthetic Collagens and Gelatin at World BioMaterials Conference

April 3, 2000
FibroGen Launches Web-Based E-Commerce Site to Sell Novel Recombinant Collagens

March 1, 2000
FibroGen Europe Appoints New Managing Director and Announces Expanded European Patent Position

. . . to 1999 press releases